Skip to main content
. 2006 Sep;174(1):285–295. doi: 10.1534/genetics.106.060517

TABLE 1.

Suppressors of par-2(it5ts) lethality

RNAi clone Gene Embryonic viability (%)a Domains and description
Vector Negative control 5.5 ± 2.6
C32E12.2 Negative control 8.4 ± 4.5
F54E7.3 par-3 75.1 ± 5.6 PDZ domains, component of the anterior PARs
T26E3.3 par-6 29.2 ± 16.1 PDZ and CRIB domains, component of the anterior PARs
F09E5.1 pkc-3 38.3 ± 19.8 Kinase domain, component of the anterior PARs
R07G3.1 cdc-42 48.2 ± 27.5 GTPase domain, activator of the anterior PARs
Y53C12B.3 nos-3 10.0 ± 6.3b Q/N-rich domain, zf-nanos-type zinc-finger domain, Drosophila Nanos and Xenopus Xcat-2 homolog
F57C2.6 spat-1 15.4 ± 5.5 Conserved in C. briggsae only
F54F2.5 ztf-1 16.3 ± 5.2 C2H2-type zinc fingers
Y48A6B.13 spat-2 32.0 ± 8.8 Conserved in C. briggsae only
Y43E12A.1c cyb-2.1 cyb-2.2 59.3 ± 6.1 Cyclin B homologs
W02A2.1 fat-2 22.7 ± 9.6 Fatty acid desaturase
ZC64.3 ceh-18 20.9 ± 7.0 POU-class homeodomain transcription factor
T13H2.5 spat-3 50.9 ± 12.1 C3HC4-type RING-finger domain and Q/N-rich domain
ZK20.5 rpn-12 48.0 ± 18.5 Component of the 26S proteasome non-ATPase regulatory particle
T06D8.8 rpn-9 22.9 ± 6.6 Component of the 26S proteasome non-ATPase regulatory particle
B0205.3 rpn-10 25.4 ± 10.3 Component of the 26S proteasome non-ATPase regulatory particle

Suppressors of par-2 (it5ts) lethality were determined by feeding RNAi clones to animals at the L1 stage. All of these clones were not identified in the genomewide screen; see text and materials and methods for details.

a

The value corresponds to the average percentage of embryos that hatched over the total number of embryos ± standard deviation over eight assays.

b

Although nos-3 was not found to suppress par-2 in this particular assay, it was included as a suppressor of par-2 since it suppressed all of the par-2 phenotypes in other assays.

c

Clone Y43E12A.1 might disrupt the function of both cyb-2.1 and cyb-2.2 since these two genes are 95% identical at the nucleic acid level.